Papers In Press, published online ahead of print January 25, 2005
J. Biol. Chem, 10.1074/jbc.M411933200
Submitted on October 20, 2004
Revised on January 25, 2005
Accepted on January 25, 2005
Par-4 Is involved in regulation of
-secretase cleavage of the alzheimer's amyloid precursor protein
Jun Xie and Qing Guo
Department of Physiology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104
Corresponding Author: qing-guo{at}ouhsc.edu
Mounting evidence indicates that aberrant production and aggregation of amyloid beta-peptide 1-42 (Abeta1-42) plays a central role in the pathogenesis of Alzheimers disease (AD). Abetais produced when amyloid precursor protein (APP) is cleaved by Abeta- and gamma-secretases at the N- and C-terminus of the Abeta peptide, respectively. The beta-secretase is membrane-bound aspartyl protease, most commonly known as BACE1. Since BACE1 cleaves APP at the N-terminus of the Abeta-peptide domain, it catalyzes the first step in Abeta-generation. Par-4 (Prostate apoptosis response-4) is a leucine zipper protein that was initially identified to be associated with neuronal degeneration and aberrant Abeta production in models of AD. We now report that C-terminal domain of Par-4 is necessary for forming a complex with the cytosolic tail of BACE1 in co-immunoprecipitation assays and in vitro pull-down experiments. Overexpression of Par-4 significantly increased, while silencing of Par-4 expression by RNA mediated interference (RNAi) significantly decreased, beta-secretase cleavage of APP. These results suggest that Par-4 may be directly involved in regulating the APP cleavage activity of BACE1. Since increased BACE1 activity observed in AD patients did not seem to arise from genetic mutations nor polymorphisms in BACE1, identification of Par-4 as an endogenous regulator of BACE1 activity may have significant implications for developing novel therapeutic strategies for AD.